SING GEORGE L

SEC Form 4 insider
REGENERON PHARMACEUTICALS, INC. ($REGN)
1 thesis · first seen Nov 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$REGNSEC Form 4bearish
Sold 21,129 @ $964.38 avg · $20,376,358 · 2026-11-02

Form 4: SING GEORGE L sold REGN

SING GEORGE L (Director at REGENERON PHARMACEUTICALS, INC.) reported an open-market sale of 21,129 shares of REGN at an average $964.38, roughly $20,376,358, in a Form 4 filed 2026-11-04.

At post $930.67Now $946.89+1.7% since postedas of Nov 4, 2:15 PM ET
View filing on SEC.gov →

End of results.